<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
        <title>Transfusion Medicine and Bone Marrow Transplantation</title>
        <meta name="viewport" content="width=device-width">

        <!-- syntax highlighting CSS -->
        <link rel="stylesheet" href="/css/syntax.css">

        <!-- Custom CSS -->
        <link rel="stylesheet" href="/css/main.css">

		<!-- Set refresh timer for local development 
		<meta http-equiv="refresh" content="10" />-->
		
    </head>
    <body>

        <div class="container">
          <div class="site">

			<h1>Transfusion Medicine and Bone Marrow Transplantation</h1>
			<p class="meta">19 Feb 2014</p>

			<div class="post">
			<h3 id='todo'>TODO</h3>

<ul>
<li>Complete lecture objectives</li>
</ul>
<span><br /></span>
<h3 id='learning_objectives'>Learning Objectives</h3>
<span><br /></span>
<h3 id='overview_of_blood_typing'>Overview of Blood Typing</h3>

<ul>
<li>Naturally occurring antibodies occur in subjects who lack the corresponding antigens: Type A patients have anti-B antibodies; Type B patients have anti-A antibodies.</li>

<li>Type AB have <strong>neither</strong> in their serum; Type O have <strong>both</strong> antibodies present in their serum; therefore the antigens present on the cell surface will be the opposite (AB have both antigens on RBC surface, O has neither on the surface.) Explains why O- is universal donor, because their RBCs are clean!</li>

<li>Immune antibodies develop in response to foreign antigens: pregnancy, transfusion.</li>
</ul>
<span><br /></span>
<h3 id='types_of_transfusion'>Types of Transfusion</h3>

<ul>
<li>Autodonation</li>

<li>Direct donation</li>

<li>Cell saver during surgery</li>

<li>Irradiated red cells and platelets</li>

<li>CMV-negative product</li>

<li>Leukocyte-reduced packed cells (get the white cells out!!) &#8220;Lymphocytes cause a lot of trouble!&#8221;</li>
</ul>
<span><br /></span>
<h3 id='what_can_be_transfused'>What can be transfused?</h3>

<ul>
<li>pRBCs: anemia, hemorrhage</li>

<li>Platelet concentrates: Use in bleeding patients regardless of platelet count, because PLT doesn&#8217;t tell you about whether or not those platelets are functioning. Also use in thrombocytopenic patients (&lt; 50k) or oncology patients (&lt; 100k). Platelets have short half life!</li>

<li>Granulocyte concentrates</li>

<li>Human plasma</li>

<li>Human albumin: volume expander, use during plasmapheresis</li>

<li>Specific factor concentrates</li>

<li>Immunoglobulin: use in hypogammaglobulinemia and autoimmune disorders</li>

<li><strong>Fresh frozen plasma</strong>: coagulation factors. Frozen within 8 hours of collection, contains all coagulation factors. Indicated for use in rapid reversal of coumadin, during massive transfusion, DIC, TTP, liver failure with coagulation defect, or Factor deficiency.</li>

<li>Q: Why do you use FFP in TTP? A: ADAMTS-13 is in there!</li>

<li>Cryoprecipitate: &#8220;heavy components of FFP&#8221; &#8211; source of fibrinogen, Factor VIII, vWF, fibronectin, FSF. Indicated for use in Von Willebrand Disease, fibrinogen deficiency,</li>

<li>Activated protein C: severe sepsis</li>
</ul>
<span><br /></span>
<h3 id='complications_of_blood_transfusion'>Complications of Blood Transfusion</h3>

<ul>
<li>Administrative issues: advise about risks and benefits, get informed consent, give right patient right blood. Transfuse blood slowly over 2-3 hours, vitaling them frequently through.</li>

<li>Adverse reactions occur in 16% of all blood transfusions; reactions categorized as immunologic, infectious, chemical, physical, or early vs. late.</li>

<li><strong>Early</strong>: adverse reactions: hemolysis, allergy, bacteremia, fluid overload, TRALI (transfusion related acute lung injury)</li>

<li><strong>Late</strong>: transmission of infectious disease, transfusional iron overload, immune sensitization</li>

<li><strong>Acute hemolytic transfusion reaction</strong>: destruction of donor red cells by preformed antibodies; naturally occurring IgM anti-A or anti-B fix complement cause rapid intravascular hemolysis. DIC then ARF, then shock. Triad of fever, back pain, and red urine.</li>

<li><strong>What to do</strong>: Stop the blood, start vigorous saline infusion. Draw red top, STAT labs. Urinalysis. Return blood to bank, have them repeat crossmatch.</li>

<li>Take home message: You need to think about every unit of blood that you transfuse, and ask - is it safe?</li>
</ul>
<span><br /></span>
<h3 id='overview_of_bone_marrow_transplantation'>Overview of Bone Marrow Transplantation</h3>

<ul>
<li>HSCs can be sourced from the bone marrow, circulating stem cells, or umbilical cord blood.</li>

<li>Patient&#8217;s stem cells are harvested and frozen, patient requiring transplant is then treated with high doses of chemotherapy and radiation, and then is re-infused with stem cells.</li>

<li><strong>Types of transplant</strong>: autologous (self), allogeneic (non-self, family vs. match), syngeneic (twin)</li>

<li>Use allogeneic transplant when the stem cells are the problem; use autologous in situations like multiple myeloma, hodgkin&#8217;s or non-Hodgkin&#8217;s lymphoma.</li>

<li><strong>Complications</strong>: #1 - Infection. Average time to immune recovery depends on cell line; PMNs 1 month, T-cells 6-12 months, B cells 12-24 months. Opportunistic infections (bacteria, Candida) move in quickly, after granulocyte recovery, concern for viruses and encapsulated bacteria. Prophylaxis with bactrim, quinolone, anti-fungal, and anti-viral agents. # 2 - Graft vs. Host disease. Only in patients with allogeneic transplants, donor cytotoxic lymphocytes attack normal host. Prophylaxis: cyclosporine, prednisone. <strong>Other complications:</strong> graft failure, vaso-occlusion, pulmonary.</li>

<li>Take home message: Quality of the donor match matters, underlying disease state matter, age of the patient matters.</li>
</ul>
<div style='text-align:center;'>
<p><img alt='' src='/assets/bone-marrow-transplant-chart.png' /></p>
</div>
			</div>
			<br>
			<hr>
            <div class="footer">
			<h6><p><a href="/">&#60; Back</a></p></h6>
			</div>
           	<div class="contact">
                <p>
					<a href="http://bquarant.github.io/">bquarant.github.io</a> | 2014 
               </p>
              </div>
          </div>
        </div>

<!-- Track traffic on gaug.es-->
		<script type="text/javascript">
		  var _gauges = _gauges || [];
		  (function() {
		    var t   = document.createElement('script');
		    t.type  = 'text/javascript';
		    t.async = true;
		    t.id    = 'gauges-tracker';
		    t.setAttribute('data-site-id', '51f19a5df5a1f51079000024');
		    t.src = '//secure.gaug.es/track.js';
		    var s = document.getElementsByTagName('script')[0];
		    s.parentNode.insertBefore(t, s);
		  })();
		</script>
    </body>
</html>